Arcturus Therapeutics Holdings (ARCT) Capital Expenditures Growth (1y) (2019 - 2025)
Arcturus Therapeutics Holdings (ARCT) Capital Expenditures Growth (1y) (2019 - 2025) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Capex Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 66,320.50 Bn | 66,320.21 Bn | - | 38.18% |
| 2 | Nanobiotix | 1,933.82 Bn | 1,933.76 Bn | - | - |
| 3 | Akari Therapeutics | 1,022.34 Bn | 1,022.34 Bn | - | - |
| 4 | BeOne Medicines | 472.93 Bn | 468.14 Bn | 1.35 Bn | -27.93% |
| 5 | Vertex Pharmaceuticals | 122.22 Bn | 114.98 Bn | 2.59 Bn | 227.76% |
| 6 | Regeneron Pharmaceuticals | 69.96 Bn | 61.21 Bn | 3.31 Bn | 0.57% |
| 7 | Belite Bio | 62.66 Bn | 62.66 Bn | - | - |
| 8 | Argenx Se | 56.07 Bn | 50.89 Bn | 1.41 Bn | - |
| 9 | Alnylam Pharmaceuticals | 37.60 Bn | 34.59 Bn | 959.66 Mn | 143.40% |
| 10 | Arcturus Therapeutics Holdings | 163.70 Mn | -47.67 Mn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Sep 30, 2025 | 126.25% |
| Mar 31, 2025 | -42.92% |
| Sep 30, 2024 | -94.48% |
| Jun 30, 2024 | -30.21% |
| Mar 31, 2024 | 124.30% |
| Dec 31, 2023 | 126.15% |
| Sep 30, 2023 | -33.71% |
| Jun 30, 2023 | 224.34% |
| Mar 31, 2023 | -94.93% |
| Dec 31, 2022 | -47,700.00% |
| Sep 30, 2022 | 573.16% |
| Jun 30, 2022 | -193.56% |
| Mar 31, 2022 | 1,688.98% |
| Dec 31, 2021 | 99.20% |
| Sep 30, 2021 | -146.15% |
| Jun 30, 2021 | 285.32% |
| Mar 31, 2021 | -54.96% |
| Dec 31, 2020 | -233.08% |
| Sep 30, 2020 | 529.56% |
| Jun 30, 2020 | -181.95% |